Magnesium Sulphate Phoenix Labs (Magnesium Sulfate)

Magnesium sulfate releases magnesium ions that compete with calcium at voltage‑gated channels, leading to vasodilation, reduced neuromuscular transmission, and central nervous system depression. This calcium antagonism stabilises neuronal membranes, prevents seizures, and helps regulate cardiac rhythm while replenishing deficient magnesium stores.

The specific dose and infusion rate are determined by the prescribing clinician based on the indication, patient weight, renal function, and serum magnesium levels. Healthcare professionals tailor the regimen to achieve therapeutic targets while avoiding toxicity.

Magnesium sulfate is commonly used in obstetric care for eclampsia and preeclampsia, but its safety profile in pregnancy is classified as unknown in some regions. It should only be administered when the benefits outweigh potential risks, and breastfeeding mothers should consult their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and necessary import documentation.

Compared with alternatives such as diazepam or phenobarbital, magnesium sulfate offers a unique mechanism as a calcium antagonist, providing both anticonvulsant and vasodilatory effects. It is preferred in obstetric seizures because it does not cross the placenta in high concentrations and has a well‑established safety record for eclampsia.

Magnesium Sulphate Phoenix Labs should be stored at temperatures below 25 °C, in its original sealed container, protected from moisture and direct light. Do not freeze the solution, and keep it out of reach of children.

The product is supplied as a sterile injectable solution for intramuscular or intravenous administration. Intravenous infusion should be performed slowly, often after an initial loading dose, while intramuscular injection is given into a large muscle mass, following aseptic technique.

The most critical risks include severe hypotension, respiratory depression, cardiac arrhythmias, and hypermagnesemia leading to neuromuscular paralysis. Continuous monitoring of blood pressure, respiratory status, and serum magnesium levels is essential to detect and manage these complications promptly.

Patients with advanced heart block without a pacemaker, severe renal impairment, known hypersensitivity to magnesium sulfate, or those receiving high‑dose calcium channel blockers should avoid this medication unless closely supervised by a specialist.